Cargando…

Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease

Cardiovascular disease (CVD) is a lifestyle-related disease (LSRD) and one of the largest public health issues. Risk factors for CVD correlate with an excessive intake of glucose and/or fructose, which has been shown to induce the production of advanced glycation end-products (AGEs). We previously i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takata, Takanobu, Sakasai-Sakai, Akiko, Ueda, Tadashi, Takeuchi, Masayoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375929/ https://www.ncbi.nlm.nih.gov/pubmed/30765817 http://dx.doi.org/10.1038/s41598-019-39202-5

Ejemplares similares

Intracellular Toxic Advanced Glycation End-Products May Induce Cell Death and Suppress Cardiac Fibroblasts
por: Takata, Takanobu, et al.
Publicado: (2022)

Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death
por: Takata, Takanobu, et al.
Publicado: (2020)

Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2020)

Generation of glyceraldehyde-derived advanced glycation end-products in pancreatic cancer cells and the potential of tumor promotion
por: Takata, Takanobu, et al.
Publicado: (2017)

Intracellular Toxic Advanced Glycation End-Products in 1.4E7 Cell Line Induce Death with Reduction of Microtubule-Associated Protein 1 Light Chain 3 and p62
por: Takata, Takanobu, et al.
Publicado: (2022)

Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2017)

Evidence for Toxic Advanced Glycation End-Products Generated in the Normal Rat Liver
por: Takata, Takanobu, et al.
Publicado: (2019)

The Association between Accumulation of Toxic Advanced Glycation End-Products and Cytotoxic Effect in MC3T3-E1 Cells
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2022)

Immunological evidence for in vivo production of novel advanced glycation end-products from 1,5-anhydro-D-fructose, a glycogen metabolite
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2019)

The Relevance of Toxic AGEs (TAGE) Cytotoxicity to NASH Pathogenesis: A Mini-Review
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2019)

Effects of Toxic AGEs (TAGE) on Human Health
por: Takeuchi, Masayoshi, et al.
Publicado: (2022)

Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD
por: Takeuchi, Masayoshi, et al.
Publicado: (2017)

Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage
por: Takeuchi, Masayoshi, et al.
Publicado: (2021)

Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis
por: Tanaka, Kenji, et al.
Publicado: (2021)

Involvement of Intracellular TAGE and the TAGE–RAGE–ROS Axis in the Onset and Progression of NAFLD/NASH
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2023)

Is the Novel Slot Blot a Useful Method for Quantification of Intracellular Advanced Glycation End-Products?
por: Takata, Takanobu
Publicado: (2023)

Potential of an Interorgan Network Mediated by Toxic Advanced Glycation End-Products in a Rat Model
por: Inoue, Shinya, et al.
Publicado: (2020)

Novel In Vitro Assay of the Effects of Kampo Medicines against Intra/Extracellular Advanced Glycation End-Products in Oral, Esophageal, and Gastric Epithelial Cells
por: Takata, Takanobu, et al.
Publicado: (2023)

Cancer Malignancy Is Enhanced by Glyceraldehyde-Derived Advanced Glycation End-Products
por: Takino, Jun-Ichi, et al.
Publicado: (2010)

Pyridoxamine and Aminoguanidine Attenuate the Abnormal Aggregation of β-Tubulin and Suppression of Neurite Outgrowth by Glyceraldehyde-Derived Toxic Advanced Glycation End-Products
por: Ooi, Hayahide, et al.
Publicado: (2022)

Toxicity of advanced glycation end products (Review)
por: Kuzan, Aleksandra
Publicado: (2021)

RasGRP2 inhibits glyceraldehyde-derived toxic advanced glycation end-products from inducing permeability in vascular endothelial cells
por: Takino, Jun-ichi, et al.
Publicado: (2021)

Neuropathy induced by exogenously administered advanced glycation end‐products in rats
por: Nishizawa, Yusuke, et al.
Publicado: (2010)

Acetaldehyde-Derived Advanced Glycation End-Products Promote Alcoholic Liver Disease
por: Hayashi, Nobuhiko, et al.
Publicado: (2013)

Cardiomyocyte oxidants production may signal to T. cruzi intracellular development
por: Dias, Patrícia Pereira, et al.
Publicado: (2017)

Glyceraldehyde-Derived Advanced Glycation End Products Accumulate Faster Than N(ε)-(Carboxymethyl) Lysine
por: Yokota, Mami, et al.
Publicado: (2017)

Assessment of the Concentrations of Various Advanced Glycation End-Products in Beverages and Foods That Are Commonly Consumed in Japan
por: Takeuchi, Masayoshi, et al.
Publicado: (2015)

Insulin resistance is an independent correlate of high serum levels of advanced glycation end products (AGEs) and low testosterone in non-diabetic men
por: Tahara, Nobuhiro, et al.
Publicado: (2010)

Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases
por: Takeuchi, Masayoshi
Publicado: (2016)

Association of advanced glycation end products in Dupuytren disease
por: Takase, Fumiaki, et al.
Publicado: (2018)

Advanced Glycation End-Product Precursor Methylglyoxal May Lead to Development of Alzheimer’s Disease
por: Li, Wai Yin, et al.
Publicado: (2022)

The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells
por: Nasu, Ryuto, et al.
Publicado: (2020)

Advanced glycation end products reduce the calcium transient in cardiomyocytes by increasing production of reactive oxygen species and nitric oxide
por: Hegab, Zeinab, et al.
Publicado: (2017)

Advanced Glycation End Products: A Sweet Flavor That Embitters Cardiovascular Disease
por: Pinto, Raphael S., et al.
Publicado: (2022)

Pentosidine, an Advanced Glycation End-Product, May Reflect Clinical and Morphological Features of Hand Osteoarthritis
por: Braun, Martin, et al.
Publicado: (2012)

Association between fingertip-measured advanced glycation end products and cardiovascular events in outpatients with cardiovascular disease
por: Hirai, Tomoya, et al.
Publicado: (2023)

Advanced glycation end products and cognitive impairment in schizophrenia
por: Kobori, Akiko, et al.
Publicado: (2021)

Pkcδ Activation is Involved in ROS-Mediated Mitochondrial Dysfunction and Apoptosis in Cardiomyocytes Exposed to Advanced Glycation End Products (Ages)
por: Yang, Yao-Chih, et al.
Publicado: (2018)

Injury of cortical neurons is caused by the advanced glycation end products-mediated pathway☆
por: Xing, Ying, et al.
Publicado: (2013)

Update on Mechanisms of Renal Tubule Injury Caused by Advanced Glycation End Products
por: Sun, Hong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hb2bnntf9cq5d86rimme8vk5lq